logo
#

Latest news with #OryzonGenomicsS.A.

European Growth Companies With High Insider Ownership To Watch
European Growth Companies With High Insider Ownership To Watch

Yahoo

time19-03-2025

  • Business
  • Yahoo

European Growth Companies With High Insider Ownership To Watch

As European markets navigate the complexities of U.S. trade tariffs and shifting monetary policies, the pan-European STOXX Europe 600 Index recently experienced a decline amid these uncertainties. In this environment, growth companies with high insider ownership can be particularly interesting to watch, as their leadership's vested interest may align with shareholder value creation during turbulent times. Name Insider Ownership Earnings Growth Elicera Therapeutics (OM:ELIC) 27.8% 97.2% Vow (OB:VOW) 13.1% 120.9% Pharma Mar (BME:PHM) 11.8% 40.8% CD Projekt (WSE:CDR) 29.7% 39.1% Bergen Carbon Solutions (OB:BCS) 12% 50.8% XTPL (WSE:XTP) 27.9% 118% Elliptic Laboratories (OB:ELABS) 22.6% 88.2% Nordic Halibut (OB:NOHAL) 29.8% 56.3% Ortoma (OM:ORT B) 27.7% 68.6% Circus (XTRA:CA1) 26% 51.4% Click here to see the full list of 229 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's uncover some gems from our specialized screener. Simply Wall St Growth Rating: ★★★★★☆ Overview: Oryzon Genomics S.A. is a clinical stage biopharmaceutical company focused on developing epigenetics-based therapeutics for cancer and CNS disorders, with a market cap of €228.43 million. Operations: Oryzon Genomics S.A. generates revenue through the discovery and development of therapeutics targeting epigenetic mechanisms for cancer and central nervous system disorders. Insider Ownership: 10.3% Earnings Growth Forecast: 54% p.a. Oryzon Genomics, a European growth company with significant insider ownership, is advancing its clinical pipeline with promising developments in psychiatric and neurodegenerative disorders. Recent announcements highlight the progression of vafidemstat into Phase III trials for Borderline Personality Disorder (BPD) following positive Phase IIb results. Despite reporting a net loss of €3.67 million in 2024, Oryzon's revenue is forecast to grow substantially at 52% annually, outpacing the Spanish market significantly. Click here to discover the nuances of Oryzon Genomics with our detailed analytical future growth report. In light of our recent valuation report, it seems possible that Oryzon Genomics is trading beyond its estimated value. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Attendo AB (publ) operates by providing health and care services across Scandinavia and Finland, with a market cap of SEK9.56 billion. Operations: The company's revenue is primarily generated from its Care and Health Care Services segment, amounting to SEK18.98 billion. Insider Ownership: 15.6% Earnings Growth Forecast: 21.2% p.a. Attendo, a European growth company with substantial insider ownership, is trading well below its estimated fair value. Its earnings are forecast to grow significantly at 21.22% annually, surpassing the Swedish market's growth rate. Despite slower revenue growth at 4% annually, recent financials show improved performance with Q4 sales rising to SEK 4.88 billion and net income doubling year-over-year to SEK 108 million. Leadership changes include Malin Fredgardh Huber as Business Area Director for Scandinavia. Click to explore a detailed breakdown of our findings in Attendo's earnings growth report. Our valuation report unveils the possibility Attendo's shares may be trading at a discount. Simply Wall St Growth Rating: ★★★★★☆ Overview: Init innovation in traffic systems SE, along with its subsidiaries, provides intelligent transportation systems solutions for public transportation globally, with a market cap of €401.96 million. Operations: The company's revenue is primarily derived from its Wireless Communications Equipment segment, which generated €245.89 million. Insider Ownership: 39.6% Earnings Growth Forecast: 27.8% p.a. init innovation in traffic systems, a European growth company with substantial insider ownership, is trading at good value compared to its peers and industry. While revenue is forecast to grow at 12.3% annually, slower than the 20% benchmark yet faster than the German market's 5.9%, earnings are expected to rise significantly by 27.78% per year, outpacing the German market's growth rate of 16.4%. Return on Equity is projected to be high at 21%. Click here and access our complete growth analysis report to understand the dynamics of init innovation in traffic systems. The valuation report we've compiled suggests that init innovation in traffic systems' current price could be quite moderate. Unlock our comprehensive list of 229 Fast Growing European Companies With High Insider Ownership by clicking here. Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance. Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include BME:ORY OM:ATT and XTRA:IXX. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store